Beta

Janus living, inc.JAN.US Overview

US StockIndustrials
(No presentation for JAN)
OverviewAI AnalysisFinancialsFinancial ForecastStock SentimentalTradingView Chart

Ticker

Value

empty

There is no following symbol in this watchlist.

JAN AI Insights

JAN Overall Performance

JAN AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

JAN Recent Performance

1.65%

Janus living, inc.

-0.42%

Avg of Sector

-0.49%

S&P500

JAN PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

Check JAN's Trend

JAN Key Information

JAN Valuation Metrics

JAN Profile

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs; and designs, develops, and sells cellular transceiver modules and associated wireless services. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.

Price of JAN

JAN FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

JAN Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.44
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
53.47%
Net Margin
13.33%
Revenue Growth (YoY)
16.36%
Profit Growth (YoY)
5112.83%
3-Year Revenue Growth
-19.42%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.44
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
53.47%
Net Margin
13.33%
Revenue Growth (YoY)
16.36%
Profit Growth (YoY)
5112.83%
3-Year Revenue Growth
-19.42%
3-Year Profit Growth
-%
  • When is JAN's latest earnings report released?

    The most recent financial report for Janus living, inc. (JAN) covers the period of 2025Q1 and was published on 2025/03/29. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating JAN's short-term business performance and financial health. For the latest updates on JAN's earnings releases, visit this page regularly.

  • What is the operating profit of JAN?

    According to the latest financial report, Janus living, inc. (JAN) reported an Operating Profit of -2.17M with an Operating Margin of -39.35% this period, representing a decline of 20.16% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is JAN's revenue growth?

    In the latest financial report, Janus living, inc. (JAN) announced revenue of 5.51M, with a Year-Over-Year growth rate of 0%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does JAN have?

    As of the end of the reporting period, Janus living, inc. (JAN) had total debt of 22.15M, with a debt ratio of 0.16. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does JAN have?

    At the end of the period, Janus living, inc. (JAN) held Total Cash and Cash Equivalents of 9.56M, accounting for 0.1 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Is JAN's EPS continuing to grow?

    According to the past four quarterly reports, Janus living, inc. (JAN)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.18. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of JAN?

    Janus living, inc. (JAN)'s Free Cash Flow (FCF) for the period is -1.54M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 183.64% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of JAN?

    The latest valuation data shows Janus living, inc. (JAN) has a Price-To-Earnings (PE) ratio of -1.93 and a Price/Earnings-To-Growth (PEG) ratio of 0.02. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.